Rating History for AbCellera Biologics (ABCL) by StoneX

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/7/2026 Robert Wasserman Upgrade Buy
(Hold)
11.00
(N/A)
7.87
(10.46)
32.91% Details